The nucleotide premixes market size is US$ 289.2 Million in 2026.
The nucleotide premixes market is projected to grow at a CAGR of 5.70% by 2033.
The nucleotide premixes market growth drivers include rising demand for functional foods, expanding infant nutrition applications, and increasing nutraceutical consumption.
North America is the dominating region for the nucleotide premixes market.
DSM Nutritional Products Ltd., F. Hoffmann-La Roche Ltd., CJ CheilJedang Corporation, ThermoFisher Scientific Inc., and Ajinomoto Co., Inc. are some leading industry players in the nucleotide premixes market.